Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., last night accepted the recommendation of her agency’s independent Advisory Committee on Immunization Practices to administer Pfizer’s pediatric COVID-19 vaccine to children between the ages of five and 11. Coupled with the Food and Drug Administration’s Oct. 29 emergency use authorization to Pfizer for its pediatric Covid-19 vaccine, this recommendation paves the way for the product’s administration to this age group immediately.

Related News Articles

Headline
The AHA July 24 announced it is collaborating with health care technology leader Epic to help hospitals adopt tools that support the early detection and…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
A Health Affairs study on the decline of obstetric services in rural and urban hospitals nationwide from 2010-2022 found that seven states had at least 25% of…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The latest video in the AHA’s series “Medicaid: Real Lives, Real Care” features Melissa Fannon-Wisner, DNP, nurse educator and nurse practitioner at Valley…
Headline
Kevin McEwan, DNP, R.N., chief nursing officer at Madison Memorial Hospital, shares how Medicaid provides vital behavioral health and maternal and child care…